# Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)

> **NCT06481345** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 300 (estimated)

## Conditions studied

- Myeloproliferative Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06481345
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481345, "Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06481345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*